Markers of Mitochondrial Biogenesis and Metabolism Are Lower in Overweight and Obese Insulin-Resistant Subjects
Leonie K. Heilbronn,
Seng Khee Gan,
Nigel Turner,
Lesley V. Campbell and
Donald J. Chisholm
Diabetes and Obesity Research Program (L.K.H., N.T., L.V.C., D.J.C.), Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia; Royal Perth Hospital (S.K.G.), School of Medicine and Pharmacology, Perth, Western Australia 6001, Australia; and School of Health Sciences (N.T.), University of Wollongong, Wollongong, New South Wales 2522, Australia
Address all correspondence and requests for reprints to: Dr. Leonie Heilbronn, Garvan Institute for Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, Australia. E-mail: l.heilbronn{at}garvan.org.au.
Background: Impaired mitochondrial function in skeletal muscleis implicated in the development of insulin resistance. However,potential differences in fatness and fitness may influence previousresults.
Methods: Subjects (n =18) were divided into insulin-sensitive(IS) and insulin-resistant (IR) groups by median glucose infusionrate during a hyperinsulinemic euglycemic clamp. Weight, VO2max(maximal aerobic capacity), and percentage body fat were measuredbefore and after 6 continuous weeks of aerobic exercise trainingat 5570% VO2max (40 min/session, 4 d/wk).
Results: Age, percentage fat, and VO2max were not differentbetween IS and IR groups at baseline. Expression of the nuclearencoded PGC1 and mitochondrial encoded gene COX1 were significantlylower in the IR group (P < 0.05). Citrate synthase activityand protein levels of subunits from complexes I and III of therespiratory chain were also lower in the IR group (P < 0.05).Insulin sensitivity and aerobic fitness were increased afterexercise training in both groups (P < 0.001), and the expressionof mitochondrial encoded genes CYTB and COX1 was also increased(P < 0.01). However, there was no change in PGC1 expression,mitochondrial enzyme activity, or protein levels of complexesof the respiratory chain in response to exercise in either group.
Conclusion: This study confirms that IR men have reduced markersof mitochondrial metabolism, independent of fatness and fitness.Moderate exercise training did not alter these markers despiteimproving fitness and whole body insulin sensitivity. This studysuggests that additional mechanisms may be involved in improvinginsulin resistance after exercise training in obese men.
This article has been cited by other articles:
V. B. Ritov, E. V. Menshikova, K. Azuma, R. Wood, F. G. S. Toledo, B. H. Goodpaster, N. B. Ruderman, and D. E. Kelley Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity
Am J Physiol Endocrinol Metab,
January 1, 2010;
298(1):
E49 - E58.
[Abstract][Full Text][PDF]
A. De Pauw, S. Tejerina, M. Raes, J. Keijer, and T. Arnould Mitochondrial (Dys)function in Adipocyte (De)differentiation and Systemic Metabolic Alterations
Am. J. Pathol.,
September 1, 2009;
175(3):
927 - 939.
[Abstract][Full Text][PDF]
M. M. Lindroos, K. Majamaa, A. Tura, A. Mari, K. K. Kalliokoski, M. T. Taittonen, P. Iozzo, and P. Nuutila m.3243A>G Mutation in Mitochondrial DNA Leads to Decreased Insulin Sensitivity in Skeletal Muscle and to Progressive {beta}-Cell Dysfunction
Diabetes,
March 1, 2009;
58(3):
543 - 549.
[Abstract][Full Text][PDF]
A. E. M. Vickers Characterization of Hepatic Mitochondrial Injury Induced by Fatty Acid Oxidation Inhibitors
Toxicol Pathol,
January 1, 2009;
37(1):
78 - 88.
[Abstract][Full Text][PDF]
M. Rao, L. Li, C. Demello, D. Guo, B. L. Jaber, B. J.G. Pereira, V. S. Balakrishnan, and the HEMO Study Group Mitochondrial DNA Injury and Mortality in Hemodialysis Patients
J. Am. Soc. Nephrol.,
January 1, 2009;
20(1):
189 - 196.
[Abstract][Full Text][PDF]
L. P Turcotte and J. S Fisher Skeletal Muscle Insulin Resistance: Roles of Fatty Acid Metabolism and Exercise
Physical Therapy,
November 1, 2008;
88(11):
1279 - 1296.
[Abstract][Full Text][PDF]
H M De Feyter, N M A van den Broek, S F E Praet, K Nicolay, L J C van Loon, and J J Prompers Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction
Eur. J. Endocrinol.,
May 1, 2008;
158(5):
643 - 653.
[Abstract][Full Text][PDF]
J. J. Dube, F. Amati, M. Stefanovic-Racic, F. G. S. Toledo, S. E. Sauers, and B. H. Goodpaster Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited
Am J Physiol Endocrinol Metab,
May 1, 2008;
294(5):
E882 - E888.
[Abstract][Full Text][PDF]
J. A. Houmard Intramuscular lipid oxidation and obesity
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2008;
294(4):
R1111 - R1116.
[Abstract][Full Text][PDF]
I. Pagel-Langenickel, D. R. Schwartz, R. A. Arena, D. C. Minerbi, D. Thor. Johnson, M. A. Waclawiw, R. O. Cannon III, R. S. Balaban, D. J. Tripodi, and M. N. Sack A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus
Am J Physiol Heart Circ Physiol,
November 1, 2007;
293(5):
H2659 - H2666.
[Abstract][Full Text][PDF]
L. K. Heilbronn, S. Gregersen, D. Shirkhedkar, D. Hu, and L. V. Campbell Impaired Fat Oxidation After a Single High-Fat Meal in Insulin-Sensitive Nondiabetic Individuals With a Family History of Type 2 Diabetes
Diabetes,
August 1, 2007;
56(8):
2046 - 2053.
[Abstract][Full Text][PDF]
P. Schrauwen Of the Fit and the Fat: Mitochondrial Abnormalities and Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
April 1, 2007;
92(4):
1229 - 1231.
[Full Text][PDF]